Wound Irrigation for Surgical Site Infection
Trial Summary
What is the purpose of this trial?
A surgical site infection (SSI) is an infection that occurs after a surgical procedure. Despite a variety of infection prevention strategies, SSIs still occur often and impose a significant burden on patients and the healthcare system. Intraoperative irrigation (or washing of the surgical incision before closure) may reduce SSIs, but this is uncertain. The Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (CLEAN Wound) trial aims to determine if incisional wound irrigation with an antiseptic or salt water solution can reduce SSIs within 30 days of surgery compared to no wound irrigation. 2,500 patients aged 18 years or older who are planned to undergo an abdominal or groin open or laparoscopic procedure will be randomly assigned to incisional wound irrigation with povidone-iodine solution; or incisional wound irrigation with saline; or no irrigation and followed for 30 days after surgery to assess the incidence of SSIs, with additional outcomes collected up to 90 days after surgery. Even with significant advances in medicine over the past decades, there are still many fundamental issues in perioperative care that remain unclear due to lack of evidence. If this trial were to demonstrate that intraoperative wound irrigation reduces the incidence of SSI, these practice-changing findings could greatly benefit patients worldwide.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Intraoperative incisional wound irrigation with povidone-iodine solution for preventing surgical site infections?
Is wound irrigation with povidone-iodine or saline safe for humans?
How does intraoperative wound irrigation with povidone-iodine or saline differ from other treatments for surgical site infections?
Intraoperative wound irrigation with povidone-iodine is unique because it significantly reduces the incidence of surgical site infections compared to saline irrigation, especially in clean-contaminated wounds, by using an antiseptic solution that kills bacteria. This method is particularly effective in reducing infections in various types of surgical incisions, unlike some other treatments that may not show significant benefits without additional antibiotics.13458
Research Team
Paul Karanicolas, MD, PhD
Principal Investigator
Sunnybrook Health Sciences Centre
Eligibility Criteria
This trial is for adults over 18 who are scheduled for certain abdominal or groin surgeries and have health insurance in Ontario. It's not for those with active infections, extremely dirty surgical sites, or allergies to povidone-iodine.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo elective surgery with randomization to incisional wound irrigation with povidone-iodine, saline, or no irrigation
Follow-up
Participants are monitored for the incidence of surgical site infections and other outcomes
Extended Follow-up
Additional outcomes such as healthcare utilization and postoperative complications are collected
Treatment Details
Interventions
- Intraoperative incisional wound irrigation with povidone-iodine solution
- Intraoperative incisional wound irrigation with saline
Intraoperative incisional wound irrigation with povidone-iodine solution is already approved in United States, European Union, Canada for the following indications:
- Prevention of Surgical Site Infections (SSIs)
- Prevention of Surgical Site Infections (SSIs)
- Skin Disinfection
- Prevention of Surgical Site Infections (SSIs)
- Skin Disinfection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor